Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02686944
What this trial is testing

Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Mendus 6
Testing effectiveness (Phase 2)Study completedNCT02638766
What this trial is testing

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Grupo Espanol de Investigacion en Sarcomas 15
Not applicableLooking for participantsNCT04557969
What this trial is testing

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Who this might be right for
Gastric CancerGastric NeoplasmGastrointestinal Stromal Sarcoma+2 more
National Cancer Institute (NCI) 400
Testing effectiveness (Phase 2)Ended earlyNCT01089595
What this trial is testing

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
GISTMetastatic Disease
Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Not applicableNot Yet RecruitingNCT07109024
What this trial is testing

Resistance Profiling Using Functional Imaging and Next Generation Sequencing in Refractory Gastrointestinal Stomal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Universität Duisburg-Essen 40
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Not applicableNo Longer AvailableNCT01689376
What this trial is testing

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer
Not applicableStudy completedNCT02662478
What this trial is testing

Laparoscopic Resection of Large Gastric Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Medical Park Gaziantep Hospital 23
Not applicableLooking for participantsNCT05938309
What this trial is testing

A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Fujian Medical University 194
Large-scale testing (Phase 3)Looking for participantsNCT05208047
What this trial is testing

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Who this might be right for
Advanced Gastrointestinal Stromal TumorsMetastatic Cancer
Cogent Biosciences, Inc. 482
Testing effectiveness (Phase 2)Study completedNCT03944304
What this trial is testing

Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 40
Early research (Phase 1)Ended earlyNCT03114319
What this trial is testing

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)+4 more
Novartis Pharmaceuticals 227
Not applicableStudy completedNCT06628739
What this trial is testing

Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes

Who this might be right for
Gastrointestinal Stromal Tumor, Malignant
First Affiliated Hospital, Sun Yat-Sen University 168
Testing effectiveness (Phase 2)Study completedNCT02880020
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
Jonsson Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Not applicableStudy completedNCT06619275
What this trial is testing

Ripretinib (QINLOCK®) According to Current SmPC

Who this might be right for
GIST - Gastrointestinal Stromal Tumor
iOMEDICO AG 10
Testing effectiveness (Phase 2)Ended earlyNCT01316263
What this trial is testing

Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Eli Lilly and Company 21
Not applicableStudy completedNCT02171286
What this trial is testing

The Oncopanel Pilot (TOP) Study

Who this might be right for
Colorectal Cancer MetastaticAdvanced Non-Small Cell Lung CarcinomaAdvanced Melanoma+2 more
British Columbia Cancer Agency 432
Testing effectiveness (Phase 2)Study completedNCT01863745
What this trial is testing

Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 15
Next Page